Verapamil ameliorates the clinical and pathological course of murine myocarditis
about
Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complexDeletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditisInfluence of myocarditis on left ventricular function.Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review.Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden deathGαq protein carboxyl terminus imitation polypeptide GCIP-27 improves cardiac function in chronic heart failure rats.Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 modelCalcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failureIdentification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.Quantitation of enteroviral RNA by competitive polymerase chain reaction.Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy.Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.Systematic evaluation of the adaptability of the non-radioactive SUnSET assay to measure cardiac protein synthesis.
P2860
Q28346540-AB7B8DF7-D30E-49D5-887A-5C36C661B8CBQ30548452-1A9FBF44-20FF-46A7-A332-58A16D9DAC8AQ33849246-76D6CF14-C529-45B5-805C-8795B4BD39ACQ33958656-5E0FA846-4954-47C7-A0CD-752122B17BE0Q34783518-6BAA255E-ABDC-4364-825A-9FEF3F3F367BQ34789751-7288D590-06DD-4097-8F05-39906D21F17FQ35231792-D6CA2B79-FD11-4C5E-A28E-24617630A6E4Q36301078-0DF8B9C7-40A1-4D73-86EA-5662D5D330D8Q37664467-6AA9D4F4-8437-4DE9-9386-A2C00E1B8930Q40042452-C9CE9EDE-27BE-4157-8DC8-A02AB71E2D9FQ40189761-A51CB7E5-6087-4603-A6C3-1772652AF8FCQ43533629-EE66649A-8DC7-4E3B-A437-8AE4DF126A74Q48667280-A874C6DC-C19F-4B2B-A742-DE0356F86F74Q53631087-A7AD09F5-5AF9-4313-9C45-46CAF007D074Q55383368-2B4808CA-4E6F-4289-8C9D-D52797285258
P2860
Verapamil ameliorates the clinical and pathological course of murine myocarditis
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@ast
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@en
type
label
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@ast
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@en
prefLabel
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@ast
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@en
P2093
P2860
P356
P1476
Verapamil ameliorates the clinical and pathological course of murine myocarditis
@en
P2093
P2860
P304
P356
10.1172/JCI116082
P407
P577
1992-11-01T00:00:00Z